TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks
Transmedics Group Inc TMDX
$84.07
▲ +1.62%
(+$1.34)
🔥 High Short Interest
Open
$82.56
Prev Close
$82.73
Day Range
$81.76 – $84.22
52W Range
$60.11 – $156.00
Market Cap
$2.92B
P/E (TTM)
19.11
Beta
2.15
EPS (TTM)
$3.73
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-02 |
| Shares Out. | 34,560,000 |
| Website | transmedics.com/ ↗ |
| Phone | 19785520900 |
| Employees | 898 |
| Revenue | $189.9M |
| Gross Profit | $113.2M |
| Net Income | $14.7M |
| Free Cash Flow | $79.0M |
| Total Assets | $1.46B |
| Total Liabilities | $946.3M |
| Equity | $518.1M |
About Transmedics Group Inc
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Transmedics Group Inc is a publicly traded company under the ticker symbol TMDX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
19 analysts (2026-09-01)